Abviva, Inc.
Abviva Announces Letter of Intent to Acquire Prion Developmental Laboratories
Published in Law and Health Weekly, December 29th, 2007
Abviva, Inc. (f/k/a Genesis Bioventures: OTCBB:GBIW) announced that it has entered into a Letter of Intent with the Receiver for Efoora, Inc. appointed by the United States District Court For The Northern District of Illinois Eastern Division (the "Court") to acquire all Prion Developmental Laboratories, ("PDL") stock owned by Efoora, Inc., PDL's current majority owner. The acquisition is subject to Abviva's due diligence, final approval by Abviva's Board of Directors and entry of an order approving the sale by the Court.
Genesis Bioventures, Inc. originally announced on July 25, 2006 that it signed a Letter of Intent with PDL to acquire the assets of PDL. At the time...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Acxiom Corporation
Consumers to Access Accounts by Voice Only - Addiction Medicine
Hythiam's PROMETA(R) Treatment Program Featured on CBS's 60 Minutes on Sunday Night - Administrative Science
Research data from North Carolina State University update understanding of administrative science - Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Completes Private Placement for $20 Million - Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Enters Into Definitive Securities Purchase Agreements for $20 Million with New and Existing Institutional Investors - Ageing
Studies from Harvard University, Medical Department describe new findings in ageing - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
